Altrinsic Global Advisors LLC Axogen, Inc. Transaction History

Altrinsic Global Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$7.26 - $10.7 $1.31 Million - $1.93 Million	-180,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.8 - $16.0 $440,000 - $800,000	50,000 Added 38.46%	180,000 $1.69 Million
Q3 2021 Nov 15, 2021	BUY	$15.23 - $21.72 $304,600 - $434,400	20,000 Added 18.18%	130,000 $2.05 Million
Q1 2021 May 14, 2021	SELL	$17.18 - $22.6 $171,800 - $226,000	-10,000 Reduced 8.33%	110,000 $2.23 Million
Q4 2020 Feb 16, 2021	BUY	$11.5 - $17.96 $230,000 - $359,200	20,000 Added 20.0%	120,000 $2.15 Million
Q3 2020 Nov 16, 2020	BUY	$10.62 - $13.12 $1.06 Million - $1.31 Million	100,000 New	100,000 $1.16 Million

176

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $745M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Altrinsic Global Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Altrinsic Global Advisors LLC with notifications on news.